| Escaping deleterious immune response in their hosts: lessons from trypanosomatids A Geiger, G Bossard, D Sereno, J Pissarra, JL Lemesre, P Vincendeau, ... Frontiers in immunology 7, 212, 2016 | 75 | 2016 |
| Inhibition of Plasmodium liver infection by ivermectin AM Mendes, IS Albuquerque, M Machado, J Pissarra, P Meireles, ... Antimicrobial Agents and Chemotherapy 61 (2), 10.1128/aac. 02005-16, 2017 | 69 | 2017 |
| Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis E Petitdidier, J Pagniez, J Pissarra, P Holzmuller, G Papierok, ... npj Vaccines 4 (1), 49, 2019 | 26 | 2019 |
| Trypanosomatid Infections: How Do Parasites and Their Excreted–Secreted Factors Modulate the Inducible Metabolism of l-Arginine in Macrophages? P Holzmuller, A Geiger, R Nzoumbou-Boko, J Pissarra, S Hamrouni, ... Frontiers in Immunology 9, 778, 2018 | 18 | 2018 |
| Hfq and RNase R mediate rRNA processing and degradation in a novel RNA quality control process RF Dos Santos, JM Andrade, J Pissarra, MP Deutscher, CM Arraiano MBio 11 (5), 10.1128/mbio. 02398-20, 2020 | 17 | 2020 |
| Proteomic Analysis of the Promastigote Secretome of Seven Leishmania Species J Pissarra, J Pagniez, E Petitdidier, M Séveno, O Vigy, R Bras-Gonçalves, ... Journal of Proteome Research 21 (1), 30-48, 2021 | 15 | 2021 |
| Pre-clinical evaluation of a P. berghei-based whole-sporozoite malaria vaccine candidate AM Mendes, IJ Reuling, CM Andrade, TD Otto, M Machado, F Teixeira, ... npj Vaccines 3 (1), 54, 2018 | 12 | 2018 |
| A systematic review of peptide-based serological tests for the diagnosis of leishmaniasis J Pagniez, E Petitdidier, O Parra-Zuleta, J Pissarra, R Bras-Gonçalves Parasite 30, 2023 | 6 | 2023 |
| Peptide-based vaccine successfully induces protective immunity against canine visceral leishmaniasis. npj Vaccines 2019; 4 (1): 49 E Petitdidier, J Pagniez, J Pissarra, P Holzmuller, G Papierok, ... NCBI, 0 | 6 | |
| Combining High-Pressure NMR and Geometrical Sampling to Obtain a Full Topological Description of Protein Folding Landscapes: Application to the Folding of Two MAX Effectors … C Dubois, M Lahfa, J Pissarra, K de Guillen, P Barthe, T Kroj, ... International Journal of Molecular Sciences 23 (10), 5461, 2022 | 3 | 2022 |
| 1H, 13C, 15 N backbone and side-chain NMR assignments for three MAX effectors from Magnaporthe oryzae M Lahfa, A Padilla, K de Guillen, J Pissarra, M Raji, S Cesari, T Kroj, ... Biomolecular NMR Assignments 16 (2), 305-309, 2022 | 2 | 2022 |
| Development of a multi-epitope peptide vaccine against human leishmaniases J da Silva Pissarra Université Montpellier, 2019 | 2 | 2019 |
| Identifying innovations produced by primary health care centers and evaluating their scalability: the SPRINT Occitanie cross-sectional study in France A Vandeventer, G Mercier, C Bonnel, J Pissarra, G Ninot, F Carbonnel BMC Health Services Research 24 (1), 824, 2024 | | 2024 |
| Predicting One-Year Mortality after Discharge Using Acute Heart Failure Score (AHFS) M Magaldi, E Nogue, N Molinari, N De Luca, AM Dupuy, F Leclercq, ... Journal of Clinical Medicine 13 (7), 2018, 2024 | | 2024 |
| 1H, 13C and 15N backbone and side-chain resonance assignments of ∆∆BmSA1, the surface antigen of Babesia microti A Mouhand, J Pissarra, S Delbecq, C Roumestand, P Barthe Biomolecular NMR Assignments 17 (2), 217-221, 2023 | | 2023 |
| SILVI, an open-source pipeline for T-cell epitope selection J Pissarra, F Dorkeld, E Loire, V Bonhomme, D Sereno, JL Lemesre, ... Plos one 17 (9), e0273494, 2022 | | 2022 |
| Development of a multi-epitope peptide vaccine against human leishmaniases| Theses. fr JDS Pissarra Montpellier, 2019 | | 2019 |
| Development of a multiepitope peptide-based vaccine against human leishmaniasis J Pissarra, P Holzmuller, L Guizani-Tabbane, JL Lemesre | | 2017 |
| Development of a new and rapid method to introduce heterologous DNA sequences into the Plasmodium genome JS Pissarra | | 2010 |
| Full wwPDB NMR Structure Validation Report i○ MA Kahsai, B Vogler, AT Clark, SP Edmondson, JW Shriver | | |
